Canopy Growth Q4 Revenue Increases 38% to $148 Million

Canopy Growth Reports Fourth Quarter and Fiscal Year 2021 Financial Results Achieves 37% revenue growth in FY 2021 with strong double-digit growth across both cannabis and other consumer products...
- June 1st, 2021 at 7:46 am

Ancillary Cannabis Stocks Dip 2.5% in May

Following up on our recent discussion of how cannabis investors have embraced publicly traded ancillary companies, New Cannabis Ventures launched its seventh proprietary index, the Ancillary Cannabis Index at the end of March....
- May 30th, 2021 at 4:26 pm

Cansortium Q1 Revenue Increases 49% to $15.1 Million

Cansortium Reports First Quarter 2021 Financial Results Q1 Revenue up 49% YoY to $15.1 Million; Adjusted EBITDA up Significantly to $4.4 Million Management to Host Conference Call Today at...
- May 28th, 2021 at 4:24 pm

HEXO to Acquire Redecan for $925 Million

HEXO Corp announces acquisition of Redecan to create Canadian market leader in adult-use sales Combined company would hold number one market-share in Canadian recreational cannabis and hold number one...
- May 28th, 2021 at 7:28 am

Cresco Labs Q1 Revenue Increases 169% to $178 Million

Cresco Labs Announces First Quarter 2021 Financial Results Under U.S. GAAP Company reports record revenue of $178 million and expects to reach annualized revenue run-rate of more than $1...
- May 27th, 2021 at 8:05 am

Valens Raises $40 Million Selling Units at $3.30

The Valens Company Announces CDN$40 Million Bought Deal Offering of Units KELOWNA, BC, May 25, 2021 /CNW/ – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company”, “The...
- May 25th, 2021 at 5:19 pm